Zydus Cadila receives USFDA nod for diabetes medicines
The US health authorities approved Sitagliptin for marketing, which was recommended to treat diabetes, on Monday, Drug company Zydus Cadila said. The business said its affiliate obtained preliminary clearance for its new Sitagliptin Base 25, 50 and 100 mg t...
6 September, 2021
Read more